Skip to main content
SpringerLink
Log in

International Breast Cancer Study Group Trials

  • Conference paper
Adjuvant Therapy of Primary Breast Cancer VI

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 152))

Abstract

The International Breast Cancer Study Group (IBCSG) is the direct successor of the Ludwig Breast Cancer Study Group, which was established in 1978 within the Bern branch of the Ludwig Institute for Cancer Research (LICR). This paper will review the history and achievements of the Group, and describe the further projects currently in the accrual and planning stages.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Bernhard J, Hürny C, Coates AS, Peterson H, Castiglione-Gertsch M, Gelber RD, Goldhirsch A, Senn H-J, Rudenstam C-M, International Breast Cancer Study Group (1997) Quality of life assessment in patients receiving adjuvant therapy for breast cancer: the IBCSG approach. Ann Oncol 8:825–835

    Article  PubMed  CAS  Google Scholar 

  • Bonadonna G, Brusamolino E, Valagussa P, Rossi A, Brugnatelli L, Brambilla C, De LM, Tancini G, Bajetta E, Musumeci R, Veronesi U (1976) Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med. 294:405–410

    Article  PubMed  CAS  Google Scholar 

  • Castiglione-Gertsch M, Tattersall MH, Hacking A, Goldhirsch A, Gudgeon A, Gelber RD, Lindtner J, Coates AS, Collins J, Isley M, Senn H-J, Rudenstam C-M, International Breast Cancer Study Group (1997) Retreating recurrent breast cancer with the same CMF-con-taining regimen used as adjuvant therapy. Eur J Cancer 14:2321–2325

    Article  Google Scholar 

  • Coates AS, Simes RJ (1993) Patient assessment of adjuvant treatment in operable breast cancer. In: Williams CJ (ed) Introducing new treatments for cancer: practical, ethical and legal problems. Wiley, Chichester, pp 447–458

    Google Scholar 

  • Early Breast Cancer Trialists’ Collaborative Group (1992) Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy. 133 randomised trials involving 31000 recurrences and 24000 deaths among 75000 women. Lancet 339:1–15, 71-85

    Google Scholar 

  • Fisher B, Carbone P, Economou SG, Frelick R, Glass A, Lerner H, Redmond C, Zelen M, Band P, Katrych DL, Wolmark N, Fisher ER (1975) L-phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings. N Engl J Med 292:117–122

    Article  PubMed  CAS  Google Scholar 

  • Fisher B, Redmond C, Brown A, Wölmark N, Wittliff J, Fisher ER, Plotkin D, Bowman D, Sachs S, Wolter J, Frelick R, Desser R, LiCalzi N, Geggie P, Campbell T, Elias EG, Prager D, Koontz P, Volk H, Dimitrov N, Gardner B, Lerner H, Shibata H (1981) Treatment of primary breast cancer with chemotherapy and tamoxifen. N Engl J Med. 305:1–6

    Article  PubMed  CAS  Google Scholar 

  • Gelber RD, Goldhirsch A (1986) A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer. J Clin Oncol 4:1772–1779

    PubMed  CAS  Google Scholar 

  • Goldhirsch A, Gelber RD, Simes RJ, Glasziou PP, Coates AS (1989) Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysis. J Clin Oncol 7:36–44

    PubMed  CAS  Google Scholar 

  • Goldhirsch A, Gelber RD, Castiglione-Gertsch M, O’Neill A, Thürlimann B, Rudenstam C-M, Lindtner J, Collins J, Forbes JF, Crivellari D, Coates AS, Cavalli F, Simoncini E, Fey M, Pagani O, Price K, Senn H-J, International Breast Cancer Study Group (1997) Menstrual cycle and timing of breast surgery in premenopausal node-positive breast cancer: results of the International Breast Cancer Study Group (IBCSG) Trial VI. Ann Oncol 8:751–756

    Article  PubMed  CAS  Google Scholar 

  • Hürny C, Bernhard J, Coates AS, Castiglione M, Peterson HF, Gelber RD, Forbes JF, Rudenstam C-M, Simoncini E, Crivellari D, Goldhirsch A, Senn H-J (1996) Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer. Lancet 347:1279–1284

    PubMed  Google Scholar 

  • Hürny C, van Wegberg B, Bacchi M, Bernhard J, Thürlimann B, Ral O, Perey L, Bonnefoi H, Coates AS (1998) Subjective health estimations (SHE) in patients with advanced breast cancer: an adapted utility concept for cancer clinical trials. Br J Cancer (in press)

    Google Scholar 

  • International Breast Cancer Study Group (1996) Duration and reintroduction of adjuvant chemotherapy for node-positive premenopausal breast cancer patients. J Clin Oncol 14:1885–1893

    Google Scholar 

  • International Breast Cancer Study Group (1997) Effectiveness of adjuvant chemotherapy in combination with tamoxifen for node-positive postmenopausal breast cancer patients. J Clin Oncol 15:1385–1394

    CAS  Google Scholar 

  • Kjellgren K, Nissen-Meyer R, Norin T (1989) Perioperative adjuvant chemotherapy in breast cancer. The Scandinavian adjuvant chemotherapy study 1. Acta Oncol 28:899–901

    Article  PubMed  CAS  Google Scholar 

  • Ludwig Breast Cancer Study Group (1984) Randomized trial of chemo-endocrine therapy, endocrine therapy and mastectomy alone in postmenopausal patients with operable breast cancer and axillary node metastasis. Lancet 1:1256–1260

    Google Scholar 

  • Ludwig Breast Cancer Study Group (1985a) A randomized trial of adjuvant combination chemotherapy with or without prednisone in premenopausal breast cancer patients with metastases in one to three axillary nodes. Cancer Res 45:4454–4459

    Google Scholar 

  • Ludwig Breast Cancer Study Group (1985b) Chemotherapy with or without oophorectomy in high-risk premenopausal patients with operable breast cancer. J Clin Oncol 3:1059–1067

    Google Scholar 

  • Ludwig Breast Cancer Study Group (1988) Combination adjuvant chemotherapy for node-positive breast cancer. Inadequacy of a single perioperative cycle. N Engl J Med 319:677–683

    Article  Google Scholar 

  • Ludwig Breast Cancer Study Group (1989) Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer. N Engl J Med 320:491–496

    Article  Google Scholar 

  • Pagani O, O’Neill A, Castiglione-Gertsch M, Gelber RD, Goldhirsch A, Rudenstam C-M, Lindtner J, Collins J, Crivellari D, Coates AS, Cavalli F, Thürlimann B, Simoncini E, Fey M, Price K, Senn H-J, International Breast Cancer Study Group (1998) Prognostic impact of amenorrhea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement. Eur J Cancer (in press)

    Google Scholar 

  • Pestalozzi BC, Peterson HF, Gelber RD, Goldhirsch A, Gusterson BA, Trihia H, Lindtner J, Cortes FH, Simmoncini E, Byrne MJ, Golouh R, Rudenstam CM, Castiglione-Gertsch M, Allegra CJ, Johnston PG (1997) Prognostic importance of thymidylate synthase expression in early breast cancer. J Clin Oncol 15:1923–1931

    PubMed  CAS  Google Scholar 

  • Stigglebout AM, Eijkemans MJC, Kiebert GM, Kievit J, Leer J-WH, de Haes JCJM (1996) The ‘utility’ of the visual analog scale in medical decision making and technology assessment. Is it an alternative to the time trade off? Int J Technol Assess Health Care 12:291–298

    Article  Google Scholar 

  • Valagussa P, Brambilla C, Zambetti M, Bonadonna G (1989) Salvage treatments in relapsing resectable breast cancer. Recent Results Cancer Res 115:69–76

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. International Breast Cancer Study Group, University of Sydney, Sydney, Australia

    A. Coates

Authors
  1. A. Coates
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Zentrum für Tumordiagnostik und Prävention, Rorschacherstrasse 150, CH-9006, St. Gallen, Switzerland

    Hans-Jörg Senn

  2. Dana Farber Cancer Institute Biostatistics, 44 Binney Street, Boston, 02115, USA

    Richard D. Gelber Ph.D

  3. Ospedale Civico, CH-6900, Lugano, Switzerland

    Aron Goldhirsch

  4. Klinik C für Innere Medizin Abteilung für Onkologie und Hämatologie, Kantonsspital St. Gallen, CH-9007, St. Gallen, Switzerland

    Beat Thürlimann

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag Berlin · Heidelberg

About this paper

Cite this paper

Coates, A. (1998). International Breast Cancer Study Group Trials. In: Senn, HJ., Gelber, R.D., Goldhirsch, A., Thürlimann, B. (eds) Adjuvant Therapy of Primary Breast Cancer VI. Recent Results in Cancer Research, vol 152. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-45769-2_41

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-45769-2_41

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-45771-5

  • Online ISBN: 978-3-642-45769-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation